GFM Network News


Aphria says proposed hostile bid undervalues company

Reuters — Canadian cannabis producer Aphria said on Friday Green Growth Brands’ proposed $2.8 billion all-stock hostile bid “significantly” undervalued the company. Ohio-based cannabis retailer Green Growth, which merged with Xanthic Biopharma in November, said on Thursday it would offer 1.5714 shares for each Aphria share. The company said its valuation was based on a […] Read more






Bayer wins U.S. nod for Monsanto deal to create ag giant

Frankfurt/Washington | Reuters — Bayer won U.S. approval for its planned takeover of Monsanto after agreeing to sell about US$9 billion in assets, clearing a major hurdle for the US$62.5 billion deal that will create by far the largest seeds and pesticides maker. Makan Delrahim, who heads the U.S. Justice Department’s (DoJ) antitrust division, said […] Read more

Bayer petitions Russian antitrust watchdog for more time in Monsanto case

Frankfurt/Moscow | Reuters — Bayer has taken Russia’s competition regulator to court over the watchdog’s investigation into the company’s planned takeover of Monsanto, a further hiccup in the US$64 billion deal amid intense antitrust scrutiny. A Bayer spokesman said the German company was petitioning the court in Russia to be given more time to discuss […] Read more


Brazilian antitrust agency approves Bayer-Monsanto tie-up

Brasilia | Reuters — Brazilian antitrust agency Cade on Wednesday approved Bayer’s proposed takeover of U.S. seeds company Monsanto without requiring further asset sales beyond a global proposal announced last October. Cade’s commissioners voted 4-2 in favour of the tie-up under an agreement, negotiated between the companies and global antitrust agencies, that included the sale […] Read more



EU review of Bayer’s Monsanto bid postponed further

Frankfurt/Brussels | Reuters — Bayer’s quest to win regulatory approval for its planned takeover of Monsanto ran into further delays on Monday as European Union antitrust investigators extended their investigation by five working days until March 12. The ongoing proceedings would have given the German drugs and pesticides maker until midnight on Monday to offer […] Read more

Aurora, CanniMed to form Canadian weed giant

Two major players in the Canadian medical marijuana market are set to create one of the world’s biggest pot production firms in a friendly $1.1 billion cash-and-stock deal. Edmonton-based Aurora Cannabis announced an agreement Wednesday in which it will ante up on its previous hostile bid for CanniMed Therapeutics and buy all the shares of […] Read more